{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:41:30Z","timestamp":1790613690594,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-026-00769-0","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T10:15:58Z","timestamp":1780136158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-risk human papillomavirus positivity and associated factors among women living with HIV in public health facilities of Mekelle, Northern Ethiopia"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-7949","authenticated-orcid":false,"given":"Mebrahtu Teweldemedhin","family":"Shfare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayelom","family":"Kahsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebrecherkos Teame","family":"Gebrehiwot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew Kahsu","family":"Abay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tekle Amare","family":"Abrha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dangew Weldegiorgis","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girmay Alemseged","family":"Kahsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fisseha Assefa","family":"Embaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerezgiher Buruh","family":"Abera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit","family":"Wolday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araya Gebreyesus","family":"Wasihun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmud Abdulkader","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsehaye Asmelash","family":"Dejene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"9","key":"769_CR1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/pathogens14090880","volume":"14","author":"X Meng","year":"2025","unstructured":"Meng X, Yang B, Yin H, Chen J, Ma W, Xu Z, Shen Y. Global burden and incidence trends in cancers associated with human papillomavirus infection: A Population-Based systematic study. Pathogens. 2025;14(9):880.","journal-title":"Pathogens"},{"issue":"8","key":"769_CR2","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/pathogens12081032","volume":"12","author":"MCT Tchouaket","year":"2023","unstructured":"Tchouaket MCT, Ka e AC, Semengue ENJ, Sosso SM, Simo RK, Yagai B, et al. Variability of high-risk human papillomavirus and associated factors among women in Sub-Saharan Africa: a systematic review and meta-analysis. Pathogens. 2023;12(8):1032. https:\/\/doi.org\/10.3390\/pathogens12081032.","journal-title":"Pathogens"},{"key":"769_CR3","first-page":"171","volume":"30","author":"A Derbie","year":"2019","unstructured":"Derbie A, Mekonnen D, Yismaw G, Biadglegne F, Van Ostade X, Abebe T. Human papillomavirus in Ethiopia. Virus Disease. 2019;30:171\u20139.","journal-title":"Virus Disease"},{"issue":"1","key":"769_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12905-023-02279-2","volume":"23","author":"T Megersa","year":"2023","unstructured":"Megersa T, Dango S, Kumsa K, Lemma K, Lencha B. Prevalence of high-risk human papillomavirus infections and associated factors among women living with HIV in Shashemene town public health facilities, Southern Ethiopia. BMC Womens Health. 2023;23(1):125.","journal-title":"BMC Womens Health"},{"issue":"1","key":"769_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10552-022-01638-y","volume":"34","author":"A Derbie","year":"2023","unstructured":"Derbie A, Mekonnen D, Nibret E, Misgan E, Maier M, Woldeamanuel Y, Abebe T. Cervical cancer in Ethiopia: a review of the literature. Cancer Causes Control. 2023;34(1):1\u20131.","journal-title":"Cancer Causes Control"},{"key":"769_CR6","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"769_CR7","unstructured":"World Health Organization (WHO). Human Papilloma virus and cancer. WHO; last updated 5 March 2024. [Accessed on 12 June 2024]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papilloma-virus-and-cancer."},{"key":"769_CR8","doi-asserted-by":"publisher","first-page":"552028","DOI":"10.3389\/fpubh.2020.552028","volume":"8","author":"AJ Kombe Kombe","year":"2021","unstructured":"Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health. 2021;8:552028. https:\/\/doi.org\/10.3389\/fpubh.2020.552028.","journal-title":"Front Public Health"},{"issue":"8","key":"769_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10147-023-02337-7","volume":"28","author":"M Kusakabe","year":"2023","unstructured":"Kusakabe M, Taguchi A, Sone K, Mori M, Osuga Y. Carcinogenesis and management of human papillomavirus-associated cervical cancer. Int J Clin Oncol. 2023;28(8):965\u201374.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"769_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s13337-023-00824-z","volume":"34","author":"S Ashique","year":"2023","unstructured":"Ashique S, Hussain A, Fatima N, Altamimi MA. HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective. VirusDisease. 2023;34(2):172\u201390.","journal-title":"VirusDisease"},{"issue":"26","key":"769_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","volume":"65","author":"LJ Viens","year":"2016","unstructured":"Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson D, Razzaghi T, Saraiya H. Human papillomavirus-associated cancers-United States, 2008\u20132012. Morb Mortal Wkly Rep. 2016;65(26):661\u20136.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"11","key":"769_CR12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356. https:\/\/doi.org\/10.1016\/S1470-2045(10)70230-8.","journal-title":"Lancet Oncol"},{"key":"769_CR13","doi-asserted-by":"publisher","first-page":"864820","DOI":"10.3389\/fonc.2022.864820","volume":"12","author":"J Williams","year":"2022","unstructured":"Williams J, Kostiuk M, Biron VL. Molecular detection methods in HPV-related cancers. Front Oncol. 2022;12:864820.","journal-title":"Front Oncol"},{"issue":"9581","key":"769_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59\u201367.","journal-title":"Lancet"},{"issue":"1","key":"769_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-020-01354-1","volume":"9","author":"KM Lekoane","year":"2020","unstructured":"Lekoane KM, Kuupiel D, Mashamba-Thompson TP, Ginindza TG. The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: Scoping review. Syst reviews. 2020;9(1):1\u20133.","journal-title":"Syst reviews"},{"issue":"6","key":"769_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","volume":"32","author":"LI Gui","year":"2018","unstructured":"Gui LI, SHARMA M, Nicholas TA. HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis. AIDS. 2018;32(6):795.","journal-title":"AIDS"},{"issue":"1","key":"769_CR17","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1038\/s41467-019-13089-2","volume":"10","author":"LJ Liebenberg","year":"2019","unstructured":"Liebenberg LJ, McKinnon LR, Yende-Zuma N, Garrett N, Baxter C, Kharsany AB, et al. HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition. Nat Commun. 2019;10(1):5227.","journal-title":"Nat Commun"},{"key":"769_CR18","unstructured":"World Health Organization (WHO). An integrated COVID-19 and the Human Papillomavirus (HPV) vaccination campaign in Tigray completed.WHO; last updated on 31 August 2023.[Accessed on 12 June 2024]. Available from: https:\/\/www.afro.who.int\/countries\/ethiopia\/news\/integrated-covid-19-and-human-papillomavirus-hpv-vaccination-campaign-tigray-completed."},{"key":"769_CR19","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2nd ed. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"769_CR20","unstructured":"World Population Review, Mekelle EP. 2024. Accessed on: November, 2024. Available at: https:\/\/worldpopulationreview.com\/cities\/ethiopia\/mekele."},{"issue":"1","key":"769_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12905-024-03249-y","volume":"24","author":"M Abdi","year":"2024","unstructured":"Abdi M, Tamiru A, Tilahun T, Tiruneh G, Fite MB. Factors associated with human papillomavirus infections among women living with HIV in public health facilities in Western Oromia, Ethiopia. BMC Womens Health. 2024;24(1):423.","journal-title":"BMC Womens Health"},{"key":"769_CR22","doi-asserted-by":"publisher","first-page":"1116685","DOI":"10.3389\/fmicb.2023.1116685","volume":"14","author":"A Seyoum","year":"2023","unstructured":"Seyoum A, Seyoum B, Gure T, Alemu A, Belachew A, Abeje D, Aseffa A, Howe R, Mulu A, Mihret A. Genotype heterogeneity of high-risk human papillomavirus infection in Ethiopia. Front Microbiol. 2023;14:1116685.","journal-title":"Front Microbiol"},{"issue":"4","key":"769_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/QAD.0000000000003437","volume":"37","author":"M Chachage","year":"2023","unstructured":"Chachage M, Parikh AP, Mahenge A, Bahemana E, Mnkai J, Mbuya W, et al. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa. AIDS. 2023;37(4):625\u201335. https:\/\/doi.org\/10.1097\/QAD.0000000000003437.","journal-title":"AIDS"},{"issue":"1","key":"769_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13027-023-00513-y","volume":"18","author":"PK Akakpo","year":"2023","unstructured":"Akakpo PK, Ken-Amoah S, Enyan NI, Agyare E, Salia E, Baidoo I, Derkyi-Kwarteng L, Asare M, Adjei G, Addo SA, Obiri-Yeboah D. High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting. Infect Agents Cancer. 2023;18(1):33.","journal-title":"Infect Agents Cancer"},{"issue":"03","key":"769_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1055\/s-0042-1748919","volume":"14","author":"B Sharma","year":"2022","unstructured":"Sharma B, Lakhanpal V, Singh K, Oberoi L, Bedi PK, Devi P. Evaluation of HPV E6\/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols. J Lab Physicians. 2022;14(03):336\u201342.","journal-title":"J Lab Physicians"},{"key":"769_CR26","unstructured":"World Health Organization. Human papillomavirus laboratory manual. Geneva: World Health Organization; 2010."},{"issue":"1","key":"769_CR27","first-page":"503432","volume":"2012","author":"M Chernesky","year":"2012","unstructured":"Chernesky M, Huang S, Jang D, Erickson B, Salituro J, Engel H, Gilchrist J, Neuscheler P, Mak WB, Abravaya K. Performance of a New HPV Cervi-Collect Collection and Transportation Kit. J Oncol. 2012;2012(1):503432.","journal-title":"J Oncol"},{"issue":"1","key":"769_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13027-023-00481-3","volume":"18","author":"A Derbie","year":"2023","unstructured":"Derbie A, Maier M, Amare B, Misgan E, Nibret E, Liebert UG, Woldeamanuel Y, Abebe T. High-risk human papillomavirus genotype distribution among women with gynecology complaints in northwest Ethiopia. Infect Agents Cancer. 2023;18(1):4.","journal-title":"Infect Agents Cancer"},{"issue":"8","key":"769_CR29","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","volume":"27","author":"M Arbyn","year":"2021","unstructured":"Arbyn M, Simon M, Peeters E, Xu L, Meijer CJ, Berkhof J, et al. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect. 2021;27(8):1083\u201395.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"769_CR30","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.cmi.2020.03.033","volume":"26","author":"M Poljak","year":"2020","unstructured":"Poljak M, Valen\u010dak AO, Domjani\u010d GG, Xu L, Arbyn M. Commercially available molecular tests for human papillomaviruses: a global overview. Clin Microbiol Infect. 2020;26(9):1144\u201350.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"769_CR31","doi-asserted-by":"publisher","first-page":"e00286","DOI":"10.1128\/JCM.00286-21","volume":"59","author":"SK Dhillon","year":"2021","unstructured":"Dhillon SK, O\u0161trbenk Valen\u010dak A, Xu L, Poljak M, Arbyn M. Clinical and analytical evaluation of the Alinity m HR HPV assay within the VAL-GENT-3 framework. J Clin Microbiol. 2021;59(6):e00286\u2013321.","journal-title":"J Clin Microbiol"},{"key":"769_CR32","unstructured":"Abbott, ALINITY m HR HPV ASSAY. Accessed on October 30, 2024. Available at: https:\/\/www.molecular.abbott\/int\/en\/products\/infectious-disease\/alinity-m-hr-hpv-assay."},{"key":"769_CR33","unstructured":"World Health Organization. WHO prequalification of in vitro diagnostics public report. Product: Xpert HIV-1 Qual Assay, WHO reference number: PQDx. 2016:0259\u2009\u2013\u200970."},{"issue":"4","key":"769_CR34","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1128\/JCM.02311-10","volume":"49","author":"FM Carozzi","year":"2011","unstructured":"Carozzi FM, Burroni E, Bisanzi S, Puliti D, Confortini M, Giorgi Rossi P, Sani C, Scalisi A, Chini F. Comparison of clinical performance of Abbott RealTi me High Risk HPV test with that of hybrid capture 2 assay in a screening setting. J Clin Microbiol. 2011;49(4):1446\u201351.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"769_CR35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/ijgc-2022-004197","volume":"33","author":"K Cuschieri","year":"2023","unstructured":"Cuschieri K, Fellner MD, M\u00fchr LS, Padalko E, Correa RM, Dillner J, Gultekin M, Picconi MA. Quality assurance in human papillomavirus testing for primary cervical screening. Int J Gynecol Cancer. 2023;33(5):802\u201311.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"769_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-025-11853-y","volume":"25","author":"S Sebsibe","year":"2025","unstructured":"Sebsibe S, Molla G, Getachew B, Eshetu Y, Gedefie A, Erkihun Y, Shibabaw A. Molecular epidemiology of high-risk human papillomavirus infection and its predictive factors among women living with HIV in Northeast Ethiopia: a facility-based cross-sectional study. BMC Infect Dis. 2025;25(1):1\u20134.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"769_CR37","doi-asserted-by":"publisher","first-page":"e0212516","DOI":"10.1371\/journal.pone.0212516","volume":"14","author":"YT Nyasenu","year":"2019","unstructured":"Nyasenu YT, Gbeasor-Komlanvi FA, Ehlan A, Issa SA, Dossim S, Kolou M, Yambiyo BM, Prince-David M, Salou M, Ekouevi DK, Dagnra A. Prevalence and distribution of Human Papillomavirus (HPV) genotypes among HIV infected women in Lom\u00e9, Togo. PLoS ONE. 2019;14(2):e0212516.","journal-title":"PLoS ONE"},{"issue":"1","key":"769_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12879-025-10827-4","volume":"25","author":"IK Agus Somia","year":"2025","unstructured":"Agus Somia IK, Purwanta ML, Winarti NW, Dwija IB, Pidari DM, Sawitri AA, Gayatri AA, Budiana IN, Pinatih KJ, Merati KT. Prevalence and risk factors of high-risk HPV and cervical abnormalities in HIV-positive women in Bali, Indonesia. BMC Infect Dis. 2025;25(1):432.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"769_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/sextrans-2019-054052","volume":"96","author":"BL Guthrie","year":"2020","unstructured":"Guthrie BL, Rositch AF, Cooper JA, Farquhar C, Bosire R, Choi R, Kiarie J, Smith JS. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya. Sex Transm Infect. 2020;96(6):457\u201363.","journal-title":"Sex Transm Infect"},{"key":"769_CR40","doi-asserted-by":"publisher","first-page":"695254","DOI":"10.3389\/frph.2021.695254","volume":"3","author":"M Lall","year":"2021","unstructured":"Lall M, Dar L, Bhatla N, Kumar P, Choudhary A, Mathur SR, Gupta RM. Prevalence of human papillomavirus (HPV) genotypes in cervicovaginal secretions of human immunodeficiency virus (HIV) positive Indian women and correlation with clinico-virological parameters. Front Reproductive Health. 2021;3:695254.","journal-title":"Front Reproductive Health"},{"issue":"10","key":"769_CR41","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/ijc.35335","volume":"156","author":"HB Kebede","year":"2025","unstructured":"Kebede HB, Mekuria S, Asegid N, Forslund O, Borgfeldt C, Jerkeman M, Mihret A, Abebe T. High-risk human papillomavirus genotypes in previously unscreened reproductive\u2010age women in Ethiopia: A community\u2010based cohort study. Int J Cancer. 2025;156(10):1995\u20132009.","journal-title":"Int J Cancer"},{"issue":"8","key":"769_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/23744235.2017.1312513","volume":"49","author":"JN Mbatha","year":"2017","unstructured":"Mbatha JN, Taylor M, Kleppa E, Lillebo K, Galapaththi-Arachchige HN, Singh D, Kjetland EF, Baay MF, Mkhize-Kwitshana ZL. High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination. Infect Dis. 2017;49(8):601\u20138.","journal-title":"Infect Dis"},{"key":"769_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijid.2020.02.051","volume":"95","author":"O Taku","year":"2020","unstructured":"Taku O, Businge CB, Mdaka ML, Phohlo K, Basera W, Garcia-Jardon M, Meiring TL, Gyllensten U, Williamson AL, Mbulawa ZZ. Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa. Int J Infect Dis. 2020;95:176\u201382.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"769_CR44","doi-asserted-by":"publisher","first-page":"e0303535","DOI":"10.1371\/journal.pone.0303535","volume":"19","author":"F Agyare Gyane","year":"2024","unstructured":"Agyare Gyane F, Modey E, Maya E, Bonney EY, Abaidoo-Myles A, Paintsil E, Torpey K. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana. PLoS ONE. 2024;19(5):e0303535.","journal-title":"PLoS ONE"},{"issue":"1","key":"769_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12879-024-09412-y","volume":"24","author":"B Traore","year":"2024","unstructured":"Traore B, Kassogue Y, Diakite B, Diarra F, Cisse K, Kassogue O, Diarra M, Coulibaly A, Coulibaly B, Diallo H, Diarra Z. Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study. BMC Infect Dis. 2024;24(1):513.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"769_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12985-020-01340-y","volume":"17","author":"SM Sosso","year":"2020","unstructured":"Sosso SM, Tchouaket MC, Fokam J, Simo RK, Torimiro J, Tiga A, et al. Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaound\u00e9, Cameroon. Virol J. 2020;17(1):69.","journal-title":"Virol J"},{"issue":"8","key":"769_CR47","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/diseases13080260","volume":"13","author":"M Mboumba-Mboumba","year":"2025","unstructured":"Mboumba-Mboumba M, Mouinga-Ondeme A, Moussavou-Boundzanga P, Engone-Ondo JD, Mounanga Mourimarodi R, Diane A, et al. The High Prevalence of Oncogenic HPV Genotypes Targeted by the Nonavalent HPV Vaccine in HIV-Infected Women Urgently Reinforces the Need for Prophylactic Vaccination in Key Female Populations Living in Gabon. Diseases. 2025;13(8):260.","journal-title":"Diseases"},{"key":"769_CR48","doi-asserted-by":"publisher","first-page":"890880","DOI":"10.3389\/fpubh.2022.890880","volume":"10","author":"A Seyoum","year":"2022","unstructured":"Seyoum A, Assefa N, Gure T, Seyoum B, Mulu A, Mihret A. Prevalence and genotype distribution of high-risk human papillomavirus infection among Sub-Saharan African women: a systematic review and meta-analysis. Front Public Health. 2022;10:890880.","journal-title":"Front Public Health"},{"key":"769_CR49","doi-asserted-by":"crossref","unstructured":"Okoye JO, Ofodile CA, Adeleke OK, Obioma O. Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review. Epidemiol Health. 2021;43.","DOI":"10.4178\/epih.e2021039"},{"issue":"3","key":"769_CR50","doi-asserted-by":"publisher","first-page":"e0264498","DOI":"10.1371\/journal.pone.0264498","volume":"17","author":"ZZ Mbulawa","year":"2022","unstructured":"Mbulawa ZZ, Phohlo K, Garcia-Jardon M, Williamson AL, Businge CB. High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention. PLoS ONE. 2022;17(3):e0264498.","journal-title":"PLoS ONE"},{"issue":"1","key":"769_CR51","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/QAI.0000000000001754","volume":"79","author":"W Mudini","year":"2018","unstructured":"Mudini W, Palefsky JM, Hale MJ, Chirenje MZ, Makunike-Mutasa R, Mutisi F, Murahwa A, Mario A. Human papillomavirus genotypes in invasive cervical carcinoma in HIV-seropositive and HIV-seronegative women in Zimbabwe. JAIDS J Acquir Immune Defic Syndr. 2018;79(1):e1\u20136.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"769_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13027-022-00442-2","volume":"17","author":"P Swai","year":"2022","unstructured":"Swai P, Rasch V, Linde DS, Mchome B, Manongi R, Wu CS, Waldstrom M, Iftner T, Mwaiselage J, Kjaer SK. Persistence and risk factors of high-risk human papillomavirus infection among HIV positive and HIV negative tanzanian women: a cohort study. Infect Agents Cancer. 2022;17(1):26.","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"769_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13027-023-00513-y","volume":"18","author":"PK Akakpo","year":"2023","unstructured":"Akakpo PK, Ken-Amoah S, Enyan NI, Agyare E, Salia E, Baidoo I, et al. High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting. Infect Agents Cancer. 2023;18(1):33.","journal-title":"Infect Agents Cancer"},{"issue":"10","key":"769_CR54","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3390\/ijerph15102210","volume":"15","author":"MI Rodr\u00edguez-\u00c1lvarez","year":"2018","unstructured":"Rodr\u00edguez-\u00c1lvarez MI, G\u00f3mez-Urquiza JL, Husein-El Ahmed H, Albend\u00edn-Garc\u00eda L, G\u00f3mez-Salgado J. Ca\u00f1adas-De la Fuente GA. Prevalence and risk factors of human papillomavirus in male patients: a systematic review and meta-analysis. Int J Environ Res Public Health. 2018;15(10):2210.","journal-title":"Int J Environ Res Public Health"},{"key":"769_CR55","doi-asserted-by":"crossref","unstructured":"Macleod CI, Reynolds JH. Human Papilloma Virus infection and cervical cancer among women who sell sex in Eastern and Southern Africa: a scoping review. Women\u2019s Health. 2021:17455065211058349.","DOI":"10.1177\/17455065211058349"},{"issue":"1","key":"769_CR56","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12879-019-3982-7","volume":"19","author":"A Ermel","year":"2019","unstructured":"Ermel A, Tonui P, Titus M, Tong Y, Wong N, Ong\u2019echa J, Muthoka K, Kiptoo S, Moormann A, Hogan J, Mwangi A. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women. BMC Infect Dis. 2019;19(1):352.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"769_CR57","first-page":"1593","volume":"20","author":"JS Smith","year":"2010","unstructured":"Smith JS, Van Damme K, Randrianjafisamindrakotroka N, Ting J, Rabozakandraina T, Randrianasolo BS, Raharinivo M, Zanasaotra S, Hobbs M, Rinas A, Cohen M. Human papillomavirus and cervical neoplasia among female sex workers in Madagascar. Int J Gynecol Cancer. 2010;20(9):1593\u20136.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"769_CR58","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/infdis\/jir560","volume":"204","author":"M Marks","year":"2011","unstructured":"Marks M, Gravitt PE, Gupta SB, Liaw KL, Tadesse A, Kim E, Phongnarisorn C, Wootipoom V, Yuenyao P, Vipupinyo C, Sriplienchan S. Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand. J Infect Dis. 2011;204(10):1505\u201313.","journal-title":"J Infect Dis"},{"key":"769_CR59","doi-asserted-by":"crossref","unstructured":"Farzaneh F, Dastyar F, Mohammadi M, Hosseini MS, Soltani A. Long-term oral contraceptive use as a risk factor for high-grade cervical lesions in women with high-risk HPV: a retrospective cohort analysis. Int J Gynecol Cancer. 2025:102650.","DOI":"10.1016\/j.ijgc.2025.102650"},{"key":"769_CR60","doi-asserted-by":"crossref","unstructured":"Marks MA, Klein SL, Gravitt PE. Hormonal contraception and HPV: a tale of differing and overlapping mechanisms. Open Access J Contracept. 2011:161\u201374.","DOI":"10.2147\/OAJC.S17404"},{"issue":"11","key":"769_CR61","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.21873\/anticanres.14620","volume":"40","author":"A Gadducci","year":"2020","unstructured":"Gadducci A, Cosio S, Fruzzetti F. Estro-progestin contraceptives and risk of cervical cancer: a debated issue. Anticancer Res. 2020;40(11):5995\u20136002.","journal-title":"Anticancer Res"},{"issue":"6","key":"769_CR62","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1159\/000525340","volume":"66","author":"R Gupta","year":"2022","unstructured":"Gupta R, Hussain S, Hariprasad R, Dhanasekaran K, Verma S, Agarwal V, et al. High prevalence of cervical high-grade lesions and high-risk human papillomavirus infections in women living with HIV: a case for prioritizing cervical screening in this vulnerable group. Acta Cytol. 2022;66(6):496\u2013506.","journal-title":"Acta Cytol"},{"key":"769_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13027-016-0061-1","volume":"11","author":"SS Menon","year":"2016","unstructured":"Menon SS, Rossi R, Harebottle R, Mabeya H, Broeck D. Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya. Infect Agents Cancer. 2016;11:17. https:\/\/doi.org\/10.1186\/s13027-016-0061-1.","journal-title":"Infect Agents Cancer"},{"issue":"4","key":"769_CR64","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1093\/infdis\/jiaf033","volume":"231","author":"C Liu","year":"2025","unstructured":"Liu C, Guo Y, Wang L, Guo R, Lei D. Association Between Herpes Simplex Virus Type 2 and High-Risk Human Papillomavirus Infections: A Population Study of the National Health and Nutrition Examination Survey, 2009\u20132016. J Infect Dis. 2025;231(4):e650\u20138.","journal-title":"J Infect Dis"},{"key":"769_CR65","doi-asserted-by":"publisher","first-page":"e01604","DOI":"10.1016\/j.idcr.2022.e01604","volume":"30","author":"IB Uysal","year":"2022","unstructured":"Uysal IB, Bou\u00e9 V, Murall CL, Graf C, Selinger C, Hirtz C, Bernat C, Ravel J, Reynes J, Bonneau M, Rahmoun M. Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case report. IDCases. 2022;30:e01604.","journal-title":"IDCases"},{"issue":"1","key":"769_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-422X-11-5","volume":"11","author":"OC Ezechi","year":"2014","unstructured":"Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IA, Odberg Pettersson K. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J. 2014;11(1):5.","journal-title":"Virol J"},{"key":"769_CR67","doi-asserted-by":"crossref","unstructured":"Okorie OC, Ohidueme OS, Banjo AA. Abnormal cervical epithelial cytology in HIV-seropositive women and correlation with CD4 counts and viral load in Uyo, Akwa Ibom State, Nigeria. infection. 2018;6:160-9.","DOI":"10.18535\/jmscr\/v6i6.28"},{"issue":"8","key":"769_CR68","doi-asserted-by":"publisher","first-page":"e015123","DOI":"10.1136\/bmjopen-2016-015123","volume":"7","author":"S Menon","year":"2017","unstructured":"Menon S, Rossi R, Zdraveska N, Kariisa M, Acharya SD, Vanden Broeck D, Callens S. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research. BMJ open. 2017;7(8):e015123.","journal-title":"BMJ open"},{"key":"769_CR69","doi-asserted-by":"crossref","unstructured":"Jibat N, Ali R, Adissu W, Buruh G, Abdissa A, Goba GK, Garland SM, Mulholland N, Mulholland K, Amenu D. Less known but greatly feared: Cervical cancer in Ethiopia, community awareness. Heliyon. 2024;10(7).","DOI":"10.1016\/j.heliyon.2024.e28328"},{"issue":"1","key":"769_CR70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13027-025-00669-9","volume":"20","author":"A Shakurnia","year":"2025","unstructured":"Shakurnia A, Salehpoor F, Ghafourian M, Nashibi R. Knowledge and attitudes toward HPV, cervical cancer and HPV vaccine among healthcare providers in Ahvaz, Southwest Iran. Infect Agents Cancer. 2025;20(1):44.","journal-title":"Infect Agents Cancer"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-026-00769-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:27:40Z","timestamp":1786505260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-026-00769-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1186\/s13027-026-00769-0","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Before the data collection, ethical approval was secured from an Institutional Review Board (IRB) of the College of Health Sciences, Mekelle University (MU-IRB 2410\/2024); permission letters were obtained from the administration of Tigray Regional Health Bureau and each of the selected health facilities. Written informed consent was obtained from all study participants. In this study, specific identifiers such as the name of the respondent and images were not used in order to maintain confidentiality. All tested women had the right to know their HPV status and were procedurally linked for VIA screening and further management. Participants receive free HPV testing, but without any other compensation payments. Overall, the ethical aspects of this research comply with the Helsinki Declaration.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"55"}}